Spectrum Pharmaceuticals, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersHawthorn Woods, IL
US patents39
SAM.gov UEISC4WFM7J1EJ3
CAGE code5BDW2
Incorporated inDE
LEI549300COU30WSP3O5I07
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
39 US patents granted 1991–2025, 7 of them in the five years to SEP 2025.
Pharmaceuticals 34Organic fine chemistry 5
- Methods of treating neutorpenia using G-CSF protein complexUS 12,350,315 · granted JUL 8, 2025
- Methods of treating neutorpenia using G-CSF protein complexUS 12,318,430 · granted JUN 3, 2025
- Methods of treatment using G-CSF protein complexUS 12,202,871 · granted JAN 21, 2025
- Methods of treating chemotherapy induced neutropenia using fixed doses of eflapegrastimUS 12,171,804 · granted DEC 24, 2024
- Crystalline forms of a quinazoline compound and its hydrochloride saltsUS 11,883,402 · granted JAN 30, 2024
Newest 5 shown · Granted to Spectrum Pharmaceuticals, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Spectrum Pharmaceuticals, INC. | Hawthorn Woods | IL | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.